Clinical trials
Phase 2 Rectal Neoplasms trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 8 |
| 2002 | 2 |
| 2003 | 1 |
| 2006 | 2 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Unknown status | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alliance for Clinical Trials in Oncology | 3 |
| National Cancer Institute (NCI) | 3 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 2 |
| Radiation Therapy Oncology Group | 2 |
| University Health Network, Toronto | 2 |
| AHS Cancer Control Alberta | 1 |
| AbbVie (prior sponsor, Abbott) | 1 |
| Alberta Health services | 1 |
| Amgen | 1 |
| Canadian Cancer Trials Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rectal Neoplasms | 30 |
| Colorectal Neoplasms | 15 |
| Colonic Neoplasms | 14 |
| Neoplasm Metastasis | 4 |
| Adenocarcinoma | 2 |
| Neoplasms | 2 |
| Adenocarcinoma, Mucinous | 1 |
| Anus Neoplasms | 1 |
| Carcinoma | 1 |
| Digestive System Diseases | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.